Winnergy Medical PCL (BKK:WINMED)

Winnergy Medical PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	649.89	654.36	639.18	703.41	538.64	530.54
Revenue Growth (YoY)	5.00%	2.37%	-9.13%	30.59%	1.53%	7.75%
Cost of Revenue	375.86	386.08	380.75	441.55	295.37	283.2
Gross Profit	274.03	268.27	258.43	261.87	243.27	247.34
Selling, General & Admin	249.83	243.8	221.37	203.68	186.24	177.86
Operating Expenses	242.02	243.8	221.37	203.68	186.24	177.86
Operating Income	32.02	24.47	37.06	58.18	57.03	69.48
Interest Expense	-14.66	-12.17	-9.07	-6.87	-4.94	-8.05
Interest & Investment Income	3.12	2.66	4.68	16.1	17.56	0
Currency Exchange Gain (Loss)	1	1.14	0.83	-	-	-
Other Non Operating Income (Expenses)	1.12	1.12	1.76	1.66	0.78	0.51
EBT Excluding Unusual Items	22.61	17.22	35.25	69.07	70.44	61.94
Gain (Loss) on Sale of Assets	0	12.19	-	-	-	-
Other Unusual Items	4.57	4.57	-	0.45	1.73	-
Pretax Income	27.18	33.97	35.25	69.52	72.16	61.94
Income Tax Expense	4.73	4.71	4.61	8.85	6.96	10.35
Net Income	22.45	29.26	30.64	60.67	65.21	51.59
Net Income to Common	22.45	29.26	30.64	60.67	65.21	51.59
Net Income Growth	-19.06%	-4.50%	-49.50%	-6.96%	26.39%	13.96%
Shares Outstanding (Basic)	400	400	400	400	359	163
Shares Outstanding (Diluted)	400	400	400	400	359	163
Shares Change (YoY)	-	-	-	11.55%	119.55%	48.48%
EPS (Basic)	0.06	0.07	0.08	0.15	0.18	0.32
EPS (Diluted)	0.06	0.07	0.08	0.15	0.18	0.32
EPS Growth	-19.06%	-4.50%	-49.50%	-16.59%	-42.43%	-23.24%
Free Cash Flow	-207.72	-67.37	-46.1	-131.78	-48.66	-30.82
Free Cash Flow Per Share	-0.52	-0.17	-0.12	-0.33	-0.14	-0.19
Dividend Per Share	0.025	0.025	0.029	0.057	0.065	0.149
Dividend Growth	-16.10%	-16.10%	-48.16%	-12.46%	-56.35%	-98.18%
Gross Margin	42.17%	41.00%	40.43%	37.23%	45.16%	46.62%
Operating Margin	4.93%	3.74%	5.80%	8.27%	10.59%	13.10%
Profit Margin	3.45%	4.47%	4.79%	8.63%	12.11%	9.72%
Free Cash Flow Margin	-31.96%	-10.29%	-7.21%	-18.73%	-9.03%	-5.81%
EBITDA	76.47	65.05	75.7	93.15	82.45	86.82
EBITDA Margin	11.77%	9.94%	11.84%	13.24%	15.31%	16.36%
D&A For EBITDA	44.45	40.58	38.64	34.96	25.41	17.34
EBIT	32.02	24.47	37.06	58.18	57.03	69.48
EBIT Margin	4.93%	3.74%	5.80%	8.27%	10.59%	13.10%
Effective Tax Rate	17.41%	13.88%	13.09%	12.73%	9.64%	16.71%
Revenue as Reported	649.89	654.36	639.18	703.41	538.64	530.54
Advertising Expenses	-	17.18	17.26	18.95	12.5	10.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.